These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 26012835

  • 1. [Advantages of NOAKs validated in clinical routine].
    Ameri AA.
    MMW Fortschr Med; 2015 May 13; 157(9):70. PubMed ID: 26012835
    [No Abstract] [Full Text] [Related]

  • 2. [Dabigatran in prevention of stroke in atrial fibrillation: three years of clinical application].
    Zotova IV, Zateĭshchikov DA.
    Kardiologiia; 2014 May 13; 54(2):79-85. PubMed ID: 24888206
    [No Abstract] [Full Text] [Related]

  • 3. Dabigatran for the prevention of stroke in atrial fibrillation: is RE-LY reliable?
    Marín F, Roldán V, Lip GY.
    Expert Opin Pharmacother; 2012 Jun 13; 13(8):1087-90. PubMed ID: 22568622
    [No Abstract] [Full Text] [Related]

  • 4. [Expanded arsenal in atrial fibrillation: bye-bye marcumar?].
    MMW Fortschr Med; 2012 Jan 19; 154(1):20. PubMed ID: 22641998
    [No Abstract] [Full Text] [Related]

  • 5. Public health. Change of heart.
    Taylor J.
    Health Serv J; 2012 Jul 26; 122(6315):19-20. PubMed ID: 23155563
    [No Abstract] [Full Text] [Related]

  • 6. Stroke prevention in atrial fibrillation.
    Wagenaar P.
    Cardiovasc J Afr; 2011 Jul 26; 22(2):105. PubMed ID: 21556458
    [No Abstract] [Full Text] [Related]

  • 7. Benefits of dabigatran maintained for more than two years.
    Aalbers J.
    Cardiovasc J Afr; 2012 Nov 26; 23(10):576. PubMed ID: 23192264
    [No Abstract] [Full Text] [Related]

  • 8. Place of dabigatran in contemporary pharmacotherapy.
    Gums JG.
    Pharmacotherapy; 2011 Apr 26; 31(4):335-7. PubMed ID: 21449622
    [No Abstract] [Full Text] [Related]

  • 9. Dabigatran: will it change clinical practice?
    Wartak SA, Bartholomew JR.
    Cleve Clin J Med; 2011 Oct 26; 78(10):657-64. PubMed ID: 21968472
    [Abstract] [Full Text] [Related]

  • 10. Australian MPs demand more data on dabigatran for atrial fibrillation.
    Brill D.
    BMJ; 2013 Jan 15; 346():f303. PubMed ID: 23321733
    [No Abstract] [Full Text] [Related]

  • 11. Risk of major bleeding and the standard doses of dabigatran.
    Antoniazzi S, Berdaï D, Conti V, Clementi E, Salvo F.
    Eur J Intern Med; 2014 Jul 15; 25(6):e73-5. PubMed ID: 24629895
    [No Abstract] [Full Text] [Related]

  • 12. Dabigatran - neurosurgical anathema?
    Thomas PA, Schaerf NB, Rosenfeld JV.
    Med J Aust; 2013 Aug 19; 199(4):238-40. PubMed ID: 23984772
    [No Abstract] [Full Text] [Related]

  • 13. Diffuse alveolar hemorrhage associated with dabigatran.
    Yokoi K, Isoda K, Kimura T, Adachi T.
    Intern Med; 2012 Aug 19; 51(18):2667-8. PubMed ID: 22989848
    [No Abstract] [Full Text] [Related]

  • 14. Stroke risk reduction: focus of the new ESC guidelines.
    Aalbers J.
    Cardiovasc J Afr; 2011 Aug 19; 22(2):106. PubMed ID: 21556459
    [No Abstract] [Full Text] [Related]

  • 15. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE, Lake JD.
    Pharmacotherapy; 2011 Aug 19; 31(8):725-8. PubMed ID: 21923597
    [No Abstract] [Full Text] [Related]

  • 16. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Zalesak M, Siu K, Francis K, Yu C, Alvrtsyan H, Rao Y, Walker D, Sander S, Miyasato G, Matchar D, Sanchez H.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):567-74. PubMed ID: 23922182
    [Abstract] [Full Text] [Related]

  • 17. Effect of dabigatran on referrals to and switching from warfarin in two academic anticoagulation management services.
    Atay JK, Fanikos J, Barnes GD, Ehle M, Coatney J, Piazza G, Froehlich JB, Goldhaber SZ.
    Am J Cardiol; 2013 Aug 01; 112(3):387-9. PubMed ID: 23647794
    [Abstract] [Full Text] [Related]

  • 18. Next generation anticoagulants may push warfarin to the wayside.
    Kirsch B.
    Manag Care; 2011 Feb 01; 20(2):33-6. PubMed ID: 21428128
    [No Abstract] [Full Text] [Related]

  • 19. Extensive postoperative ecchymosis in a patient taking dabigatran.
    Wagner CA, Oberoi N, Ahluwalia PK.
    J Minim Invasive Gynecol; 2013 Feb 01; 20(1):127-30. PubMed ID: 23312256
    [Abstract] [Full Text] [Related]

  • 20. [Atrial fibrillation: what the GP needs to know].
    Diener HC, Kaeufer T, Bode C.
    MMW Fortschr Med; 2011 Sep 22; 153(38):44-7; quiz 48. PubMed ID: 21977796
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.